Pyrazinamine (PZA) is one of the most commonly prescribed anti-tuberculosis (anti-TB) drug due to its ability to significantly shorten the TB treatment period. However, excess PZA in the body causes hepatotoxicity and liver damage. This, therefore, calls for new methods for ensuring reliable dosing of the drug, which will differ from person to person due to interindividual differences in drug metabolism. A novel biosensor system for monitoring the metabolism of PZA was prepared with nanocomposite of multi-walled carbon nanotubes (MWCNTs), polyaniline (PANI) and cytochrome P450 3A4 (CYP3A4) electrochemically deposited on a glassy carbon electrode (GCE). The nanocomposite biosensor system exhibited enhanced electroactivity that is attributable to the catalytic effect of the incorporated MWCNTs. The biosensor had a sensitivity of 7.80 µA/µg mL -1 PZA and a dynamic linear range of 4.92 -160 ng/mL PZA.
Introduction
Pyrazinamide (PZA) is one of the first-line drugs in the multi-drug regimen treatment of tuberculosis (TB), which affects one third of the world [1] at a rate of one new infection per second.
Pyrazinamide (see structure in Fig. 1 ) is normally administered along with ethambutol, isoniazid and rifampicin. PZA is the most effective of the four drugs and has been proven to shorten tuberculosis therapy from nine months to the current six months duration [2] . The metabolic clearance of PZA varies from person to person due to the polymorphic behaviour of enzymes, leading to different rates at which the drugs are metabolized. Such variations lead to severe side effects caused by the accumulation of the drug in the human system. The most common side effects of PZA include hepatotoxicity and liver damage, which calls for very sensitive and reliable devices for their monitoring [3] .
Electrochemical methods are being developed for fast on-site monitoring of drugs. [4] . Some of theese methods involve the use of conductive polymers. This calss of polymers have been intensively researched on as platforms for the immobilisation of enzymes during biosensor fabrication. In biosensor systems the polymers act as receptors for biomolecule and mediators for electron transport between the electrode and the active site of the biomolecule [5] . Most common and widely studied polymers include polyaniline, polypyrrole, polyacetylene and polythiophene [6, 7] . Polyaniline (PANI) has attracted much interest among academic and industrial researchers due to its outstanding electrochemical, optical, physical, chemical and mechanical properties; together with its environmental stability and ease of preparation by chemical or electrochemical procedures [8] [9] [10] .
Though PANI has applications in sensors, electronics devices and batteries, it is normally conductive in acidic mediums, which limits its application [11] . The modification or tuning of the conductivity properties of PANI can be effected with nanomaterials, transition metal oxides and organic dopants [12] . Carbon nanotubes (CNTs) have been intensively applied the development of biosensors due to their unique structural, electronic and mechanical properties [13] . They are characterised by large surface area and high conductivity which result in enhanced performance of CNT nanocomposites with other materials. Several studies have also demonstrated that CNTs enhance the electrochemical reactivity of immobilized biomolecules by promoting faster electron transfer reactions [14] . In this study a multi-walled carbon nanotbe (MWCNT) has been combined with PANI to produce a biocompatible platform for the immobilisation of cytochrome P450 3A4 (CYP3A4) for the preparation of a novel nanobosensor system for the determination of PZA.
Experimental
Reagents. Aniline (93.13%) was purchased from Sigma Aldrich, South Africa and was purified by The XRD patterns in Fig. 4 consist of sharp well-resolved peaks at 26.0˚ and 26.5˚ associated with carbon (002) in MWCNTs [15, 16] and PANI [17] , respectively. The distinctive sharpness of the peaks is indicative of the crystallinity of both MWCNTs and PANI [17] . However, in the nanocomposite (MWCNT-PANI) the characteristic XRD peak value shited to 25.8˚ due to the bonding between PANI and MWCNTs.
Electrochemical Properties. The nanocomposite was characterized using cyclic voltammetry (CV) and differential pulse voltammetry (DPV). The CV graphs ( Fig. 5A ) have three redox processes corresponding to A/A′ (+ 260/+210 mV), B/B′ (+480/+560 mV) and C/C′ (+590/+620 mV) at lower scan rates. The redox process A/A′, B/B′ and C/C′ can be attributed to the leucoemeraldine/leucoemeraldine radical cation, emeraldine radical cation/emeraldine and pernigraniline radical cation/pernigraniline states of PANI, respectively [18, 19] . At higher scan rates, there are two redox pairs with peak C broadening out and disappearing at scan rates of 50 to 60 mV s -1 . It can therefore be concluded that the rate at which the pernigraniline radical cation gains an electron is very slow. The voltammograms correspond to a reversible system with I p,a (peak A)/I p,c (peak A′) value of 1.2 and ∆E p = E p,a (peak A) -E p,c (peak A′) < 57/n mV. These are characteristic of a surface adsorbed species undergoing fast reversible electron transfer reaction [18] .
There is a distinct increase in the current density with increasing scan rates between the scan rates of 10 and 60 mV/s. There is also an observed shift in the peak potential for redox pairs A/A′ and C/C′ which is indicative of electron hopping along the polymer chain [20] . Response Dynamics of PZA Nanobiosensor. The electrocatalytic behaviour of the biosensor was investigated in the presence and absence of PZA as shown in Fig. 6 . The necessity of oxygen during the enzymatic reaction was also investigated. In the presence of oxygen, there was an increase in the cathodic peak current with an onset potential of -160 mV which is indicative of the oxygenation of 66 Nano Hybrids Vol. 6
CYP2EI heme Fe atom being coupled to the electron transfer reaction that occurs in argon degassed medium represented by voltammogram 'a'. Then, in the presence of 1.96 µM PZA, there was a developement of a large cathodic catalytic wave with a peak at -490 mV. Inset is an expansion of SWVs for -650 to +300 mV.
This behaviour was only observed for the biosensor in the presence of PZA. Voltammogram 'c'
consists of a shift of the electron transfer cathodic peak potential (E pc ) from -25 mV in argon medium to -50 mV in oxygenated PZA solution. This implies that the electron transfer at the GCE/PANI/MWCNT/CYP2E1 electrode that occurred at -25 mV was followed by (i) the binding of PZA to CYP2EI that shifts the E pc to -50 mV, (ii) the oxygenation (binding of O 2 ) of PZA-CYP2E1 at -160 mV and (ii) the reduction of PZA-CYP2E1-O 2 starting at an onset potential of -300 mV reaching a peak at -490 mV. This result is in agreement with the mechanism for the metabolic reaction of cytochrome P450 (heamolytic) enzymes [21] [22] [23] . Figure 6 is the plot of the square wave voltammograms (SWVs) of the biosensor responses to PZA. After the first addition, a catalytic current response resulting from the reduction of PZA was observed at -460 mV. The reduction peak Nano Hybrids Vol. 6 67 current increased with increasing concentrations of PZA. This behaviour is attributed to the coupling of the fast electron transfer at the electrode surface with the reduction of PZA on or within the biosensor film [12] . The increase in current is proportional to the amount of the analyte. There was also an observed anodic shift in the peak potential, which is attributed [21] [22] [23] to the ease of redution of the CYP2E1 heme Fe from Fe 3+ to Fe 2+ , brought about by the PZA-induced convesrion of low spin Fe 3+ to high spin Fe 3+ (the later being easier to reduce to Fe 2+ that preferentially binds O 2 ).
The peak currents calculated from the SWVs of Fig. 7 inset have a linear relationship with PZA concentrations (see Fig. 8 [24] . This falls within the DLR of the GCE/PANI/MWCNT/CYP2E1 nanobiosensor.
However, from LC analysis of human blood [25] the peak concentration (C max ) of PZA determined 2 h after drug intake is 3.44 -4.09 µg/mL, which is very detectatable with the nanobiosensor due to its high sensitivity (current). 68 Nano Hybrids Vol. 6
Conclusion
The CV results demonstate that the biosensing process occurs via an oxygenation reaction which culminates in the enzymatic hydroxylation of pyrazinamide to pyrazinoic acid. The reaction is a net 2-electron reduction process in which the first electron is used to reduce Fe 3+ of CYP2E1 to Fe 2+ , and the second electron is for splitting the O-O bond of the PZA-CYP2E1-O 2 intermediate [26, 27] . The sensitivity of the biosensor is very much enhanced by the incorporation of MWCNTs into the MWCNT-PANI nanocomposite platform used in the construction of the nanobiosensor. The C max for 500 mg PZA administered to TB patients in Cape Town area of South Africa is 1.47 µg/mL [25] .
This level of PZA can be determined by the PZA nanobiosensor. Also the DLR of the biosensor can be extended to cover higher concentrations by increasing the PANI-MWCNT film thickness during electropolymerisation and enzyme incorporation steps. Considering that PZA causes liver damage in combination with the occurrence of inter-individual variability in drug metabolic ability due to genetic polyporphysm, the determination of very low levels of PZA (with GC/MWCNT/PANI/CYP2E1 nanobiosensor) in biopsy samples of various biological organs will be essential in controlling drug dossage.
